Companies / Nanopath
Nanopath
Cambridge, United States
Nanopath has developed a molecular diagnostic platform to enable scalable, point-of-care disease diagnosis
Nanopath, based in Cambridge, United States, has 3 investors on file, among them Creative Destruction Lab, GingerBread Capital and Undeterred Capital.
SEC Form D filings
2 filingsFiled by Nanopath Inc with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Accelerator | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Nanopath and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Creative Destruction Lab adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/nanopathdx.com/investors
# also
GET /v1/companies/nanopathdx.com
GET /v1/companies/nanopathdx.com/news